The osteoporosis drug Fosamax has been associated with an increased risk of jaw and bone decay. Lawsuits are being reviewed nationwide.

Please note that the lawyers at Saiontz & Kirk, P.A. are no longer taking on new cases involving Fosamax. The content on this page is provided for informational purposes only.

Fosamax (generic name alendronate sodium) is a bisphosphonate medication prescribed for treatment and prevention of osteoporosis, osteopenia and Paget’s disease of the bone.

The medication increases bone mass density and reduces the occurrence of fractures for patients with osteoporosis.  However, studies have shown that it has the opposite effect in several bones and joints, causing decay of the jawbone, hip, shoulder, and knee. It has also been linked to an increased risk of femur fractures, or broken thigh bones, with long-term Fosamax use.

The manufacturers of Fosamax, Merck, failed to adequately warn about the risk of problems and bone deterioration with the medication. The lawyers at Saiontz & Kirk, P.A. are reviewing potential lawsuits for individuals who have been diagnosed with osteonecrosis of the jaw, osteonecrosis of the hip, osteonecrosis of the knee or osteonecrosis of the shoulder.

New cases are no longer being accepted by Saiontz & Kirk, P.A. This page is maintained for informational purposes only.

FOSAMAX STATISTICS

Fosamax was approved in October 1995 by the US Food and Drug Administration (FDA).  The drug was the first non-hormonal therapy treatment for postmenopausal osteoporosis in the United States.

  • Fosamax and Fosamax Plus D are currently the most prescribed medicine for osteoporosis.
  • In 2003, Fosamax was listed as the 19th most prescribed medication in the United States
  • Nearly 20 million patients have been taken the drug.
  • Fosamax averaged sales of more than $3 billion dollars a year for Merck as of 2005

>>INFORMATION: Fosamax Alternatives

LAWSUITS AGAINST FOSAMAX

If you or a family member have taken Fosamax and been diagnosed with osteonecrosis of the jaw, experienced symptoms of jaw death, or suffered from shoulder, hip or knee osteonecrosis, you should seek a free consultation regarding your legal rights.  We can investigate your potential claim as a result of Merck’s failure to warn of the Fosamax side effects.  Our Fosamax lawyers have the experience and resources to fight the pharmaceutical company and make sure you obtain the compensation you may be entitled to.

New cases are no longer being accepted by Saiontz & Kirk, P.A. This page is maintained for informational purposes only.